Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults

NCT05393869 | Completed Results DMC

• 3 other identifiers: OSU-20427NCI-2022-02543K99CA260718
• Study Type: interventional
• Target: 2,849
• Locations: 1 country
• Sites: 1

Brief Summary

This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.

Conditions

Tobacco-Related Carcinoma

Outcome Measures

Primary Outcomes (4)

• Message Perceived Effectiveness - Persuasive Potential.

  6 items measured on 5-point scale, 1 = Not at all and 5 = Very much * These messages were worth remembering. * These messages grabbed my attention. * These messages are powerful. * These messages are convincing. * These messages are meaningful. * These messages are informative. Responses were summed and averaged to create a scale for intention to quit (range from 1 - 5). Higher scores indicate a higher persuasive potential of the message.

  Immediately post-exposure to intervention, up to 1 hour

• Perceived Effectiveness - Perceived Behavioral Impact

  Six items were analyzed separately, each scored on 5-point Likert scale (1=Strongly Disagree, 5=Strongly Agree) These messages will motivate CIGARETTE SMOKERS to switch to vaping. These messages will motivate people to quit ALL smoking and vaping. These messages will motivate NON-USERS to start vaping. These messages will motivate NON-USERS to start smoking cigarettes. These messages will motivate CIGARETTE SMOKERS to quit. These messages will motivate VAPERS to quit.

  Immediately post-exposure to intervention, up to 1 hour

• Risk Perceptions: Absolute/Relative Risks of Cigarette vs. E-cigarette Use

  On a scale from 0-10, where 0 = not at all harmful and 10 = extremely harmful now harmful are ... to your health? * combustible cigarettes * nicotine vapes On a scale from 0-10, where 0 = much less harmful and 10 = much more harmful... • compared to combustible cigarettes, how harmful are nicotine vapes to your health?

  Immediately post-exposure to intervention, up to 1 hour

• Behavioral Intentions to Use Tobacco

  8-items made up two 4-pt scales (1 = definitely will not and 4 = definitely will). Items for each scale were summed and averaged. Higher scores indicate higher likelihood of avoiding cigarettes/nicotine vapes. How likely it is that in the next 3 months, you will refrain from... * smoking cigarettes completely and permanently? * smoking cigarettes when you get lonely? * smoking cigarettes when you are with your friends who use them? * smoking cigarettes when someone hands you a cigarette? How likely it is that in the next 3 months, you will refrain from... * vaping nicotine completely and permanently? * vaping nicotine when you get lonely? * vaping nicotine when you are with your friends who use them? * vaping nicotine when someone hands you a vape?

  Immediately post-exposure to intervention, up to 1 hour

Study Arms (7)

AR-Quit

EXPERIMENTAL

Participants view messages with absolute risk and quit statements

Other: Health communications

AR-Switch

EXPERIMENTAL

Participants view messages with absolute risk and switch statements

Other: Health communications

AR-Combination

EXPERIMENTAL

Participants view messages with absolute risk and combination quit+switch statements

Other: Health communications

RR-Quit

EXPERIMENTAL

Participants view messages with comparative risk and quit statements

Other: Health communications

RR-Switch

EXPERIMENTAL

Participants view messages with comparative risk and switch statements

Other: Health communications

RR-Combination

EXPERIMENTAL

Participants view messages with comparative risk and combination quit+switch statements

Other: Health communications

Control

OTHER

Participants view FDA regulatory messages

Other: Health communications

Interventions

Health communications OTHER

Participants are assigned to view health communications with risk and efficacy statements.

AR-Combination; AR-Quit; AR-Switch; Control; RR-Combination; RR-Quit; RR-Switch

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Young adults (age 18-35 years)
• Live in the United States
• At least 50% of the sample also:
• Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)

Sponsors & Collaborators

• Ohio State University Comprehensive Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location

Related Links

• The Jamesline

MeSH Terms

Interventions

Health Communication

Intervention Hierarchy (Ancestors)

Health Care Facilities Workforce and Services

Results Point of Contact

• Title: Dr. Joanne G. Patterson
• Organization: The Ohio State University College of Public Health

patterson.1191@osu.edu

614-247-1780

Study Officials

• Joanne G Patterson, PhD MPH MSW

  Ohio State University Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 18, 2022
• First Posted: May 26, 2022
• Study Start: April 14, 2021
• Primary Completion: November 14, 2022
• Study Completion: November 14, 2022
• Last Updated: December 26, 2023
• Results First Posted: December 26, 2023

Record last verified: 2023-12

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)